NCT04884217 - Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

October 30, 2021

Study Completion Date

December 30, 2021

Conditions

Dry Eye SyndromeKeratoconjunctivitis Sicca

Interventions

DRUG

Pro-ocular™ Topical Gel

Pro-ocular™ Topical Gel 1% is applied dermally to the forehead twice-daily

DRUG

Placebo Topical Gel

Placebo is a toopical gel without active ingredient applied dermally to the forehead twice-daily

Trial Locations (1)

Tri-Service General Hospital, National Defense Medical Center, Taipei